Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Lett Appl Microbiol ; 70(3): 210-220, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31838746

ABSTRACT

Fusarium basal rot is a worldwide disease problem in onions, and causes substantial losses in onion production, both during the growing season and in the storage. To minimize the post-harvest losses, a protocol for screening of latent infections with pathogenic Fusarium oxysporum strains from harvested onions was developed. This protocol is based on a dual PCR test with primers specific for the fungal species and new SIX3 primers specific for the onion-pathogenic F. oxysporum strains. A pooled sample containing pieces from 50 harvested symptomless onions was prepared for the dual PCR using microwave disruption of the filamentous Fusarium fungi and Whatman FTATM filter paper matrix technology, or as a reference protocol, by extracting DNA with a commercial kit. The two sample preparation protocols gave consistent results with the tested onion samples. Detection limit of the dual PCR protocol was 100 pg of F. oxysporum DNA, in a mixture with onion DNA, when the FTA card was applied. The new protocol reported here is simple and sensitive enough for routine testing, enabling the detection of latent infections in harvest lots even at the infection levels under 10%. SIGNIFICANCE AND IMPACT OF THE STUDY: Fusarium basal rot causes serious problems in onion production. To minimize post-harvest losses, a simple protocol based on FTATM technology and a dual PCR test with Fusarium oxysporum species-specific and pathogenicity-specific primers was developed. By testing pooled onion samples using this method, latent infections with F. oxysporum can be screened from a representative sample of the harvest. This screening method could be a useful tool to manage the post-harvest losses caused by latent infections with F. oxysporum and, with modification of the PCR protocol, with other Fusarium species pathogenic to onion.


Subject(s)
Fusarium/genetics , Fusarium/isolation & purification , Onions/microbiology , Plant Diseases/microbiology , DNA Primers/genetics , Polymerase Chain Reaction
2.
Minerva Endocrinol ; 31(1): 61-73, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16498364

ABSTRACT

Aromatase enzyme encoded by CYP19 gene is responsible for the formation of estrone and estradiol from C19 androgens, androstenedione and testosterone. Several lines of evidence suggest an important role for the estrogens as well as androgens in the key pathogenic processes of Alzheimer's disease (AD) such as amyloid beta (Abeta) production, hyperphosporylation of tau protein, oxidative stress and apoptosis. Moreover, epidemiological studies suggest a neuroprotective role for estrogen in AD for which reason estrogen replacement therapies have been extensively studied as a way to improve the cognition and to lower the risk of AD. Aromatase enzyme is a key player in this context as it controls estrogen biosynthesis and, therefore, it may exert neuroprotective effects via increasing the local estrogen levels in injured neurons. Consistent with this idea, brain injury in mice and rats rapidly up-regulates aromatase enzyme expression in glial cells at the injury site suggesting that aromatase may be involved in protection of injured neurons through increased estrogen levels. Additional support for the role of aromatase in AD originates from the recent genetic studies, which have shown that single nucleotide polymorphisms in CYP19 gene are independently or in synergy with other AD risk genes increasing the susceptibility for AD. These genetic findings suggest that CYP19 gene encompasses functional alterations, which may affect stability, expression or activity of the aromatase enzyme. Characterization of these novel alternations may ultimately reveal new avenues to understand and design new therapeutic approaches to AD.


Subject(s)
Alzheimer Disease/enzymology , Aromatase/physiology , Estrogens/biosynthesis , Nerve Tissue Proteins/physiology , Aged , Aged, 80 and over , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Amyloid beta-Protein Precursor/metabolism , Androgens/metabolism , Aromatase/deficiency , Aromatase/genetics , Brain/enzymology , Case-Control Studies , Cross-Sectional Studies , Estrogen Replacement Therapy , Estrogens/physiology , Female , Genetic Predisposition to Disease , Humans , Male , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Organ Specificity , Polymorphism, Single Nucleotide , Postmenopause , Prospective Studies , Protein Processing, Post-Translational , RNA, Messenger/metabolism
4.
Neuroscience ; 137(4): 1143-52, 2006.
Article in English | MEDLINE | ID: mdl-16326017

ABSTRACT

The brain is an important target organ for peripherally synthesized estrogen but it also has its own steroid biosynthesis producing estrogen from testosterone catalyzed by the aromatase enzyme. This study examined the effects of estrogen treatment in two spatial memory tasks, one-arm-baited radial arm maze and a position discrimination task in the T-maze in ovariectomized female mice. Hippocampal cytochrome P450 19 (encoding aromatase), and estrogen receptor alpha and beta gene expressions were also measured using real time quantitative polymerase chain reaction analysis. Estrogen (17beta-estradiol) was administered either tonically via s.c. minipellets or phasically via daily i.p. injections. In ovariectomized mice, the tonic estrogen decreased the number of reference memory errors in radial arm maze. Tonic estrogen treatment also up-regulated the expression of cytochrome P450 19 and estrogen receptors. In contrast, estrogen injections decreased the expression of cytochrome P450 19 and estrogen receptor alpha genes. The number of reference memory errors correlated negatively with estrogen receptor alpha expression. These findings indicate that peripheral estrogen levels affect neuronal estrogen synthesis by regulating the cytochrome P450 19 gene expression and also influence estrogen receptor alpha expression. The results also suggest that tonic rather than cyclic estrogen treatment might be more beneficial for cognitive functions.


Subject(s)
Aromatase/genetics , Estradiol/pharmacology , Estrogen Receptor alpha/genetics , Estrogen Receptor beta/genetics , Hippocampus/enzymology , Maze Learning/drug effects , RNA, Messenger/genetics , Space Perception/drug effects , Animals , Female , Gene Expression Regulation/drug effects , Mice , Mice, Inbred C57BL , Ovariectomy , RNA, Messenger/drug effects , Transcription, Genetic/drug effects
5.
J Neurol Neurosurg Psychiatry ; 75(12): 1746-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15548496

ABSTRACT

OBJECTIVES: Neprilysin (NEP) is an amyloid beta-peptide (Abeta) degrading enzyme expressed in the brain, and accumulation of Abeta is the neuropathological hallmark in Alzheimer's disease (AD). In this study we investigated whether polymorphisms in the NEP gene have an effect on the risk for AD. METHODS: The frequencies of seven single nucleotide polymorphisms (SNPs) and apolipoprotein E (APOE) were assessed in 390 AD patients and 468 cognitively healthy controls. Genotypes of the study groups were compared using binary logistic regression analysis. Haplotype frequencies of the SNPs were estimated from genotype data. RESULTS: Two SNPs, rs989692 and rs3736187, had significantly different allelic and genotypic frequencies (uncorrected p = 0.01) between the AD and the control subjects and haplotype analysis showed significant association between AD and NEP polymorphisms. CONCLUSION: Taken together, these findings suggest that polymorphisms in the NEP gene increase risk for AD and support a potential role for NEP in AD.


Subject(s)
Alzheimer Disease/genetics , Neprilysin/genetics , Polymorphism, Genetic , Aged , Case-Control Studies , Female , Finland , Genotype , Humans , Male , Risk Factors
6.
Neurology ; 63(1): 173-5, 2004 Jul 13.
Article in English | MEDLINE | ID: mdl-15249634

ABSTRACT

The authors previously reported that genetic variation in the gene coding for nicastrin (NCSTN) modified risk for familial early-onset Alzheimer disease (AD) in a Dutch population-based sample. Risk was highest in patients without an APOE epsilon4 allele. Here, they evaluated if NCSTN polymorphisms increased risk of AD in the eastern Finnish population. A significant difference in one haplotype was observed in AD patients without the APOE epsilon4 allele.


Subject(s)
Alzheimer Disease/genetics , Membrane Glycoproteins/genetics , Polymorphism, Single Nucleotide , Aged , Alzheimer Disease/epidemiology , Amyloid Precursor Protein Secretases , Apolipoproteins E/genetics , Female , Finland/epidemiology , Genes, Dominant , Genetic Predisposition to Disease , Genotype , Haplotypes/genetics , Humans , Male , Membrane Proteins/genetics , Middle Aged , Presenilin-1 , Presenilin-2
7.
Neurology ; 62(7): 1170-6, 2004 Apr 13.
Article in English | MEDLINE | ID: mdl-15079018

ABSTRACT

BACKGROUND: Brain aromatase may be neuroprotective by increasing the local estrogen levels in injured neurons. Aromatase is encoded by the CYP19 gene located at 15q21.1, a chromosomal region in linkage disequilibrium (LD) with Alzheimer disease (AD) in this sample. OBJECTIVE: To investigate whether nine single-nucleotide polymorphisms (SNP) spanning the CYP19 gene were associated with AD. METHODS: Three hundred ninety-four patients were compared with 469 nondemented control subjects using single-locus and haplotype approaches. Haplotypes were identified using the expectation/maximization algorithm and latent class analysis, which included additional information on age, sex, and APOE polymorphism. RESULTS: Allelic and genotypic frequencies for three adjacent SNP differed between AD and control groups. Both haplotype approaches identified an approximately 60% increase (p = 0.02) in the risk of AD for one haplotype and similar levels of excess risk irrespective of APOE polymorphism and gender. CONCLUSION: Genetic variation in the brain aromatase gene may modify the risk for AD.


Subject(s)
Alzheimer Disease/enzymology , Alzheimer Disease/genetics , Aromatase/genetics , Polymorphism, Single Nucleotide , Adult , Aged , Alzheimer Disease/epidemiology , Apolipoproteins E/genetics , Female , Finland/epidemiology , Gene Frequency , Genetic Variation , Genotype , Haplotypes , Humans , Linkage Disequilibrium/genetics , Male , Middle Aged , Odds Ratio , Risk Assessment
8.
Exp Neurol ; 187(1): 105-17, 2004 May.
Article in English | MEDLINE | ID: mdl-15081593

ABSTRACT

We investigated the effects of ovariectomy (OVX) and 17 beta-estradiol (0.18 mg per pellet) treatment on spatial learning and memory, hippocampal beta amyloid (A beta) levels, and amyloid plaque counts in double transgenic mice (A/P) carrying mutated amyloid precursor protein (APPswe) and presenilin-1 (PS1-A246E). After OVX at 3 months of age, the mice received estrogen treatment for the last 3 months of their lifetime before they were killed at 6, 9, or 12 months of age. Estrogen treatment in A/P OVX mice increased the number of correct choices in a position discrimination task in the T-maze, and slightly improved their performance in a win-stay task (1/8 arms baited) in the radial arm maze (RAM). However, estrogen treatment did not reverse the A beta-dependent cognitive deficits of A/P mice in the water maze (WM) spatial navigation task. Furthermore, ovariectomy or estrogen treatment in OVX and sham-operated A/P mice had no effect on hippocampal amyloid accumulation. These results show that the estrogen treatment in a transgenic mouse model of Alzheimer's disease (AD) improves performance in the same learning and memory tasks as in the normal C57BL/6J mice. However, the estrogen effects in these mice appeared to be unrelated to A beta-induced cognitive deficits. Our results do not support the idea that estrogen treatment decreases the risk or alleviates the symptoms of Alzheimer's disease by inhibiting the accumulation of A beta or formation of amyloid plaques.


Subject(s)
Alzheimer Disease/drug therapy , Estrogens/pharmacology , Maze Learning/drug effects , Plaque, Amyloid/metabolism , Spatial Behavior/drug effects , Age Factors , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Animals , Disease Models, Animal , Estradiol/pharmacology , Female , Hippocampus/metabolism , Hippocampus/pathology , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Organ Size/drug effects , Ovariectomy , Peptide Fragments/metabolism , Plaque, Amyloid/pathology , Presenilin-1
9.
Neuroscience ; 113(2): 301-10, 2002.
Article in English | MEDLINE | ID: mdl-12127087

ABSTRACT

Seladin-1 is a gene recently shown to be down-regulated in brain regions selectively degenerated in Alzheimer's disease. The sequence of seladin-1 shares similarities with flavin-adenine-dinucleotide-dependent oxidoreductases and it has been found to protect cells from apoptotic cell death. In this work, we show that the transcription of seladin-1 is selectively down-regulated in the brain areas affected in Alzheimer's disease. The down-regulation in seladin-1 transcription was associated with hyperphosphorylated tau seen as linkage to immunohistochemically detected paired helical filament tau, neuritic plaques and neurofibrillary tangles. In contrast, no association was found between seladin-1 transcription and beta-amyloid deposition when analyzing human samples or tissue from transgenic animals. Furthermore, the relative transcription of seladin-1 was found to fluctuate during aging in the transgenic mouse model of Alzheimer's disease. The fluctuation was enhanced by Alzheimer's disease causing mutations in presenilin-1 and amyloid precursor protein genes. Finally, seladin-1 transcription was found to be up-regulated in mouse N2a cells induced to undergo apoptosis with okadaic acid. The results presented here indicate that seladin-1 transcription is selectively down-regulated in brain regions vulnerable to Alzheimer's disease and this down-regulation is associated with the hyperphosphorylation of tau protein.


Subject(s)
Alzheimer Disease/genetics , Nerve Tissue Proteins/genetics , Oxidoreductases Acting on CH-CH Group Donors , Aged , Aged, 80 and over , Animals , Apoptosis/physiology , Brain/physiopathology , Cadaver , Chromosomal Proteins, Non-Histone/genetics , Down-Regulation , Female , Humans , Male , Mice , Mice, Transgenic/genetics , Nerve Degeneration/genetics , Transcription, Genetic
10.
Tree Physiol ; 19(14): 951-958, 1999 Dec.
Article in English | MEDLINE | ID: mdl-12651307

ABSTRACT

We examined effects of nutrient availability and changing root zone temperature (RZT) on growth, gas exchange and plasma membrane H(+)-ATPase (PM-ATPase) activity of roots of 1-year-old Scots pine (Pinus sylvestris L.) seedlings during spring flushing. The 6-week growth-chamber experiment was carried out in hydroponic cultures that supplied the seedlings with low (0.5 mM N) or high (3 mM N) nutrient concentration and two rates of increase in RZT were simulated: slow warming (SW-treatment) and fast warming (FW-treatment). Air temperature, humidity, and light conditions were similar in all treatments. Growth of roots and shoots was retarded at low RZT, and fresh mass increment of roots was closely correlated with RZT sum. High nutrient availability increased nitrogen concentrations of needles and stems, but only at RZTs >13 degrees C. Low RZT and low availability of nutrients suppressed gas exchange of the seedlings. Real PM-ATPase activity was highly dependent on RZT. At high RZTs, real PM-ATPase activity was affected by nutrient availability but this effect was related to root growth. We conclude that, under conditions of high nutrient availability, Scots pine seedlings can compensate for the suppressive effects of long-term exposure to low RZT by rapidly accelerating growth, gas exchange and root metabolism, but only when RZT has increased above a threshold value, which was 13 degrees C in this study.

SELECTION OF CITATIONS
SEARCH DETAIL
...